M
10b5-1 Plan
$ Value
$0
Shares
6,349
Price
$0
Filed
May 13
Insider
Name
Rodman David Malcom
Title
Chief Medical Officer
CIK
0001672659
Roles
Officer
Transaction Details
Transaction Date
2025-05-12
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
101,577
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024. | The stock option vested with respect to 25% of the underlying shares on July 12, 2022, and vests with respect to the remaining shares in 36 substantially equal monthly installments thereafter.
Filing Info
Rodman David Malcom's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-17 | MLYS | M | $6K |
| 2026-04-17 | MLYS | ▼ | $13K |
| 2026-04-17 | MLYS | M | $0 |
| 2026-04-15 | MLYS | ▼ | $176K |
| 2026-04-13 | MLYS | M | $7K |
| 2026-04-13 | MLYS | M | $36K |
| 2026-04-13 | MLYS | M | $59K |
| 2026-04-13 | MLYS | ▼ | $373K |
| 2026-04-13 | MLYS | M | $0 |
| 2026-04-13 | MLYS | M | $0 |
Other Insiders at MLYS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $8.8M | — | 2026-03-30 |
| AKKARAJU SRINIVAS | — | — | 2026-02-19 |
| SBLENDORIO GLENN | — | — | 2026-02-19 |
|
Congleton Jon
Chief Executive Officer
|
— | $2.4M | 2026-04-13 |
|
Rodman David Malcom
Chief Medical Officer
|
— | $1.9M | 2026-04-17 |
|
Levy Adam Scott
CFO and Secretary
|
— | — | 2026-02-19 |
| DiRocco Derek | — | — | 2026-02-19 |
| Karydas Daphne | — | $75K | 2026-03-31 |
| Slingsby Brian Taylor | — | — | 2026-02-19 |
| Gold Alexander M | — | — | 2026-02-19 |